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Abstract
Background: Based in epidemiological evidence, repetitive ovulation has been proposed to play a role in the
origin of ovarian cancer by inducing an aberrant wound rupture-repair process of the ovarian surface epithelium
(OSE). Accordingly, long term cultures of isolated OSE cells undergo in vitro spontaneous transformation thus
developing tumorigenic capacity upon extensive subcultivation. In this work, C57BL/6 mouse OSE (MOSE) cells
were cultured up to passage 28 and their RNA and DNA copy number profiles obtained at passages 2, 5, 7, 10,
14, 18, 23, 25 and 28 by means of DNA microarrays. Gene ontology, pathway and network analyses were focused
in passages earlier than 20, which is a hallmark of malignancy in this model.
Results: At passage 14, 101 genes were up-regulated in absence of significant DNA copy number changes. Among
these, the top-3 enriched functions (>30 fold, adj p < 0.05) comprised 7 genes coding for centralspindlin, chromosome
passenger and minichromosome maintenance protein complexes. The genes Ccnb1 (Cyclin B1), Birc5 (Survivin), Nusap1
and Kif23 were the most recurrent in over a dozen GO terms related to the mitotic process. On the other hand,
Pten plus the large non-coding RNAs Malat1 and Neat1 were among the 80 down-regulated genes with
mRNA processing, nuclear bodies, ER-stress response and tumor suppression as relevant terms. Interestingly, the
earliest discrete segmental aneuploidies arose by passage 18 in chromosomes 7, 10, 11, 13, 15, 17 and 19. By passage
23, when MOSE cells express the malignant phenotype, the dysregulated gene expression repertoire expanded, DNA
imbalances enlarged in size and covered additional loci.
Conclusion: Prior to early aneuploidies, overexpression of genes coding for the mitotic apparatus in passage-14
pre-malignant MOSE cells indicate an increased proliferation rate suggestive of replicative stress. Concomitant
down-regulation of nuclear bodies and RNA processing related genes suggests altered control of nuclear RNA
maturation, features recently linked to impaired DNA damage response leading to genome instability. These
results, combined with cytogenetic analysis by other authors in this model, suggest that transcriptional profile at
passage 14 might induce cytokinesis failure by which tetraploid cells approach a near-tetraploid stage containing
primary chromosome aberrations that initiate the tumorigenic drive.
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Background
Non-heritable, sporadic ovarian cancer (OC) continues
to be the major cause of death by gynecological cancer
in western countries [1]. Early detection markers of OC
are not yet available resulting in diagnosis at advanced
stages with poor prognosis. Nearly 90 % of OC tumors
including carcinomas, cystadenomas, and borderline
tumors are histologically related to the ovarian surface
epithelium (OSE), a single layer of flat to cuboidal cells
wrapping the ovary [2]. Importantly, repeated wound
damage-repair of the OSE due to continuous, uninter-
rupted ovulatory cycles, remains as one of the current
mainstream views proposed as OC initiating mechanism
[3]. An alternative, recent notion, suggest that OC of the
serous carcinoma type originates from the fallopian tube
epithelium [4].
The uninterrupted ovulation theory finds additional
support in epidemiological data on reproductive history
of women. Conditions with reduced number of ovulation
cycles such as pregnancies, anovulatory contraception
and breastfeeding, confer a significantly reduced OC risk
[5–7]. Conversely, continuous ovulation as in nulliparity,
increases OC risk [8]. Ovulation is essentially a pro-
inflammatory process triggered by a luteinizing hormone
(LH) surge leading to increase of reactive oxygen species
(ROS) levels in ovarian follicles [9]. Indeed, ROS scaven-
gers placed in the ovarian bursa of mice can impair
ovulation [10]. At the site of follicular rupture, OSE cells
undergo apoptosis and adjacent cells become exposed to
oxidants and inflammatory signals [11].
The OSE is an extension of the peritoneal mesothe-
lium. It is loosely attached to a basement membrane that
separates it from the underlying stroma rich in dense
collagenous fibers [2]. Since the OSE express epithelial,
mesothelial and mesenchymal markers, it has been con-
sidered as an “uncommitted” or mixed epithelium. OSE
cells additionally express hormone receptors for gonado-
tropins (FSHR, LHR, GnRH type I), activin/inhibin
(ACVR), estrogen (ERα/β) and progesterone (PRA/B)
[2]. As the ovary reaches reproductive senescence, OSE
cells invaginate to form cortical epithelial crypts and inclu-
sion cysts that have been proposed to be pre-neoplastic le-
sions [12]. In contrast to the mixed phenotype of the OSE,
inclusion cysts predominantly express epithelial markers,
a phenotype consistent with an atypical reverse epithelial-
mesenchymal transition (EMT) observed in OC tumors
[13]. While early ovarian carcinomas display increased
expression of E-cadherin, an epithelial cell marker, ad-
vanced OC cells partially recover mesenchymal features,
thus decreasing E-cadherin expression [14].
Due to its proposed relevance in OC initiation, OSE
cells from diverse sources have been characterized as ex-
perimental models of ovarian carcinogenesis. Rodent OSE
cells detached from the ovaries undergo spontaneous
transformation after repeated subcultivation [15, 16].
Furthermore, when injected in the peritoneal cavity of im-
munocompetent animals, such spontaneously transformed
mouse OSE (MOSE) cells induce tumor implants and
hemorrhagic ascites [15, 17], features typical of advanced
human OC [18]. Therefore, the proliferative pressure im-
posed on cultured MOSE cells seems to induce a trans-
formation path resembling the naturally in vivo process of
repetitive wound damage-repair.
Importantly, the progression from a pre-malignant non-
tumorigenic to an aggressive phenotype has been moni-
tored in the MOSE culture model [15, 17, 19–21]. Altered
actin cytoskeleton, reduced focal adhesion plaques, E-
cadherin down-regulation and subcellular mislocalization
of connexin-43 (Gja1) among other parameters, have been
used to define sequential stages of cell transformation
[19]. Massive cell cytoskeleton disorganization was found
to be mediated by dysregulation of about 140 genes
coding for components of actin filaments, microtu-
bules and intermediate filaments. In addition, altered
global patterns of ser/tyr phosphorylation plus APC
and PKCII mislocalization paralleled the remodeling
of cellular architecture [20].
Cytogenetic changes have been also studied in the
MOSE model [21]. By passage 19, diploid and tetraploid
cells coexisted. By passage 26, mononucleated tetraploid
cells - initially binucleated diploid due to citokinesis fail-
ure- become predominant over undetectable diploid
cells. Bipolar or multipolar mitosis occasionally occurs
during proliferation of mononucleated tetraploid cells
leading to chromosome mis-segregation and near-
tetraploid aneuploidy [21]. In the present work we aimed
to uncover gene networks underlying very early stages of
MOSE transformation. At passage 14, we detected dys-
regulation of three key protein complexes and numerous
additional genes involved in chromosome dynamics dur-
ing cell division. In addition, the first detectable aneu-
ploidies were identified at passage 18. We propose that
these early transcriptional alterations would be both pri-
marily implicated in cytokinesis failure of initial diploid
cells, and also in anomalous mitosis leading to aneu-
ploidy and tumorigenicity of late-passage, tetraploid
MOSE cells.
Results and discussion
Strategy for genomic and transcriptional profiling of
MOSE cells
We have previously used the NIA-15 K microarray plat-
form to study the transcriptomic and DNA copy number
(array-CGH) profiles of established, late passage malig-
nant, clonal MOSE cell lines [22, 23]. Figure 1 illustrates
the experimental and analytical scheme followed in the
present work. Distinct, common reference samples for
RNA (transcriptomic) and DNA (genomic) microarray
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hybridizations were used. Dye-swap was applied to
counteract gene-specific labeling bias [24] whereas
print-tip loess normalization plus inter-slide scale per-
centile adjustment allowed us to minimize experimental
variability of the microarray procedure arising from vari-
ous sources [25]. The complete, normalized RNA dataset
for 15,023 probes in 35 microarrays corresponding to 9
samples (i.e., 4 replicates in RNA samples of passages 2, 5,
10, 14, 18, 23, 25 and 28, plus 3 replicates in samples of
passage 7) is available as the Additional file 1 (Urzua_R-
NA_dataset.xls). Passage designation is hereafter referred as
pX, where X = 2, 5, 7, 10, 14, 18, 23, 25 and 28. RNA data
were deposited to GEO (http://www.ncbi.nlm.nih.gov/geo/)
with the accession code GSE81729.
The in vitro transformation experiment of MOSE
cells [15] has been reproduced by several laboratories
[17, 19, 21]. Based on multiple growth parameters,
Roberts et al defined early, intermediate and late stages of
MOSE transformation [19]. Early (E) stage corresponded
to p4-15 while early-intermediate (E/I) comprised cells at
p20-35. In the original work of Roby et al [15], p20 was
the hallmark of pre-malignancy to malignancy. Consist-
ently, E-stage cells grew as single monolayers that did not
form spheroids whereas E/I-stage cells were able to invade
the collagen support and formed <50 μm spheroids [19].
Therefore, as this evident phenotypic transition should
rely on a gene-expression switch occurring before than
p20, we aimed to examine early, pre-malignant transcrip-
tomic and genomic changes in a shorter time-course, i.e.,
every 3–4 passages. Then, taking the transcriptomic pro-
file of MOSE cells at p2 as “baseline”, paired limma tests
with profiles of p5, 7, 10, 14, 18, 23, 25 and 28 were con-
ducted to identify significant differentially expressed genes
(DEG) during the course of the transformation process
using an adjusted p-value < 0.01 as cut-off. The p2-
baseline transcriptome assumption implies that: i) p2 cells
are the closest state to in vivo, “native” transcription; and
ii) any extent of differential gene expression after p2, re-
flects adaptation of MOSE cells to culture conditions in
early passages and might reveal their intrinsic and spon-
taneous drift leading to aneuploidy-mediated transform-
ation in later passages. The same rationale was applied to
analyze genomic DNA (array-CGH) data for which the
baseline was a self-to-self experiment conducted with a
reference, normal germline DNA. In this case, we thought
reasonable assuming that genomic DNA of MOSE cells at
p2 would be undistinguishable from germline DNA, and
that any DNA copy number variation arising in later pas-
sages would be unequivocally detected with this approach.
In addition to the limma analysis, the whole array-CGH
Fig. 1 Microarray hybridization design and data analysis pipeline. Genomic DNA and total RNA profiles of MOSE cells were obtained with cDNA
microarrays. Double arrows in opposite directions indicate that a common reference design plus repeated dye-swap design was used for the two
series. Reference DNA was genomic DNA isolated from peripheral whole blood of adult C57BL6 male mice. Reference RNA was from a whole
newborn male C57BL/6 mouse (Wnbm) as in previous studies [21, 22]. Test RNA and DNA samples were co-purified from the same cultures
samples, labeled and hybridized on NIA-15 K cDNA microarrays as described [22]. Raw RNA and DNA datasets were separately normalized by
print-tip loess with DNMAD. Limma (linear analysis of microarray data) analysis was performed in Pomelo2. DNA data was visualized in chromosomal
format and smoothed with the WebaCGH tool [60]. Differential expression and copy number were subjected to functional genomics analyses (see
details in Results section)
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dataset was put in chromosomal display by applying a
smoothing algorithm and z-score filters (see Methods).
Figure 2a depicts the number of statistically significant
probes (FDR adjusted p < 0.01) in the RNA and the
DNA experiments for the MOSE cells culture passage
series. Earliest DEGs detected at p5 corresponded to 13
up-regulated and 31 down-regulated genes, the latter
enriched in GO:2000377 (regulation of reactive oxygen spe-
cies metabolic process; 4 genes; p = 1.5e-04), GO:0006807
(nitrogen compound metabolic process; 16 genes; p = 8.6e-
04) and GO:0033554 (cellular response to stress; 8 genes;
p = 1.3e-03). Among genes classified under GO:2000377,
Cryab encodes for a HSP20-related, oxidative stress
protein, able to suppress nasopharyngeal tumors by inter-
fering β-catenin function [26] while Cyp1b1 decreases
oxidative stress in endothelial cells [27]. Therefore,
downregulation of both Cryab and Cyp1b1 might be
regarded as an oxidative stress initiator at p5. Regard-
ing DNA results, an array-CGH data subset of about 60
clones was significantly altered at p7, but when placed
in chromosomal context did not mark any loci. We
cannot rule out if this DNA data actually correspond to
micro-deletions and/or micro-amplifications remaining
cryptic due to the limited resolution of this array plat-
form. However, as much less significant DNA data was
found in later p10 and p14, such putative cryptic gains
and losses at p7 might be regarded as transient, i.e., they
do not persist across successive cell sub-cultivation.
We found that transcriptional alterations were in part
permanent or transitory along MOSE pre-malignant
transformation. Figure 2b attempts to clarify this result
by using boolean comparisons for selected culture pas-
sages. Only 8 out of the 44 DEG at p5 were conserved
by p14. In turn, of 181 DEG at p14, 139 were transient
and 34 persisted until p18. Interestingly, DNA copy
number alterations dramatically emerged at p18, which
was the only stage that lacked “exclusive” differential
expression. In addition to the 34 genes shared with pre-
cedent p14, 76 additional genes persisted to the subse-
quent p23, in which cells express the tumorigenic
phenotype. Thus, p18 might be considered a transitional
period in which copy-number alterations emerge in the
presence of a more stable and discrete transcriptional
repertoire respect to earlier and later passages.
Further boolean comparisons were done between over-
lapping genes in p14 versus p18, p18 versus p23 and p23
versus p28 comparisons shown in Fig. 2b. Seventeen genes
were permanently down-regulated and 3 genes were per-
manently up-regulated from p14 through p28. Among the
first group, Arhgef12, Ctsb, Ctsh, Malat1 and Sfpq were
classified under the biological terms described in Table 1.
Notably, Arhgef12 has been described as a tumor suppres-
sor while Malat1 and Sfpq participate in biogenesis of
paraspeckles (see below). The 12 remaining down-
regulated transcripts included 2010111I01Rik, Sorbs2,
Phf17, Ubr3 and Fth1, catalogued under the term
GO:0046914 (transition metal ion binding). On the other
hand, the 3 up-regulated genes persisting until p28 were
Hs6st2, a heparan-sulfate sulfotransferase linked to EGF-
like induced angiogenesis in OC cells [28], Hmga1, coding
for a non-histone chromosomal protein recently proposed
as a diagnostic urine marker in serous epithelial OC [29]
and Mmp2, a matrix metallopeptidase implicated in OC
metastasis [30]. Interestingly, though high Malat1 expres-
sion has been linked to cell proliferation and metastasis, a
recent study suggest a tumor-suppressor role of Malat1 in
gliomas through inhibition of ERK/MAPK signaling and
Mmp2-mediated invasiveness [31], findings consistent
with its down-regulation in our model.
Dysregulated transcription prior to DNA copy number
alterations
Given the particular transcriptomic and DNA copy-
number profile of p18, it was reasonable to hypothesize
Fig. 2 Summary of differential transcription and DNA aberrations
during MOSE transformation. Chart a shows the number of statistically
significant probes (adjusted FDR p < 0.01) corresponding to non-
redundant cDNA clones of the NIA-15 K collection for both the RNA
and the DNA experiments across MOSE culture passages as indicated.
The Venn diagram in b depicts exclusive and common DEGs among
sequential passages, each after individual comparison to passage 2
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that DEG in previous p14 could lead MOSE cells towards
a genomic instability process. Table 1 shows a gene ontol-
ogy (GO) analysis of the 101 up-regulated plus the 80
down-regulated transcripts at p14 in the MOSE model.
Notably, among up-regulated genes, the top-3 enriched
functions (>30 fold) comprised genes coding for central-
spindlin, chromosome passenger and minichromosome
maintenance (MCM) protein complexes, a set of struc-
tures essential for dynamics of mitosis. The centralspindlin
complex is composed of the molecular motor Kif23 and
the GTPase activating protein Racgap1, the latter upregu-
lated in gastric, colorectal and breast cancer [32–34]. In
addition, the GO terms chromatin assembly, chromosome
condensation, sister chromatid segregation, kinetochore,
cytokinesis, histone binding, spindle, mitotic nuclear div-
ision, histone deacetylase binding and centrosome covered
a total of 34 genes among which Ccnb1 (Cyclin B1), Birc5
(Survivin), Nusap1 (NuSAP) and Kif23 (mitotic kinesin-
Table 1 Ontology and pathway analysis of genes dysregulated at passage 14
Terma Genes Enrichment Adj p-value
Up-regulated (53/101 unique genes)
Centralspindlin complex Racgap1, Kif23 72.4 2.4e-03
Chromosome passenger complex Cdca8, Birc5 48.3 5.1e-03
MCM complexb Mcm2, Mcm3, Mcm6 31.1 1.5e-03
Chromatin assembly Mcm2, Cenpa, Hmga1, Hmga2, Chaf1b, H2afz 15.1 2.0e-04
Chromosome condensation Ncapd2, Nusap1, Top2a, Hmga2, Ccnb1 17.3 5.0e-04
Sister chromatid segregation Ccnb1, Cdca8, Knstrn, Ncapd2, Nusap1, Top2a 11.2 3.2e-04
Kinetochore Birc5, Ccnb1, Cenpa, Knstrn, Trp53bp1 9.9 1.5e-02
Cytokinesis Racgap1, Nusap1, Kif23, Birc5, Ckap2, Anln, Prc1 8.1 8.0e-04
Steroid metabolic process Lss, Hsd17b12, Fdft1, Msmo1, Ldlr, Mvd, Hmgcr 6.1 1.3e-03
Nucleotide metabolic process Dhfr, Gapdh, Gmpr, Hmgcr, Pkm, Pnkp, Rrm2, Taldo1, Tk1, Tpi1 5.8 5.2e-04
Histone binding Chaf1b, Hist1h4n, Mcm2, Ncapd2, Trp53bp1,Uhrf1 5.5 2.7e-02
Spindle Racgap1, Kif23, Cdca8, Birc5,Dlgap5, Ccnb1, Knstrn1, Nusap1, Prc1 5.3 1.5e-03
Extracellular matrix Itgb1, Gpc3, Fbln2, Fn1, Hsd17b12, Anxa2, Mmp2, Pkm, Rpsa 4.6 3.3e-03
Mitotic nuclear division Anln, Birc5, Ccna2, Ccnb1, Ccnb2, Cdc20, Cdca8, Hmga2, Kif23, Knstrn,
Ncapd2, Nusap1, Racgap1, Triobp
4.3 5.0e-04
Histone deacetylase binding Cdc20, Hsp90ab1,Top2a 4.2 2.4e-02
Centrosome Ccnb1, Kif23, Tcp1, Cdc20, Krt18, Ccnb2, Cdca8, Birc5, Dlgap5, Ckap2,
Mcm3, Tacc3
4.1 1.0e-03
Negative regulation of Wnt signaling Gpc3, Hmga2, Nxn 4.0 3.4e-02
Down-regulated (35/80)
mRNA processingc Ddx3x, Ttc14, Clk4, Rps24, Eif4a2, Sfpq, Matr3, Clk1, Rbms1, Srsf11, Zfml 17.1 5.0e-11
Unfolded & misfolded protein binding Hsp90b1, Hspa5, Dnaja2, Dnajc3 10.6 3.2e-02
Histone acetyl transferase activity Crebbp, Ogt 9.1 2.1e-02
Cysteine-type peptidase activity Ctsb, Ctsh, Otud7b, Senp6, Usp3 8.7 1.2e-02
Response to ER stress Dnajc3, Hsp90b1, Hspa5, Itpr1, Pdia3, Pdia4 8.3 7.5e-03
Nuclear body Neat1, Sfpq, Malat1, Atrx, Crebbp 7.6 3.5e-02
Regulation of chromosome organization Atrx, Ogt, Paxbp1, Pten, Senp6, Sfpq 5.5 1.3e-02
Wnt signaling pathway Ddx3x, Ndrg2, Pten 3.1 4.7e-02
Apoptotic signaling in response to DNA damage Cdip1, Nupr1 2.8 3.3e-02
Tumor suppressiond Crebbp, Ddx3x, Eef1a1, Pten, Hsp90b1, Arhgef12
Nupr1, Pdcd4, Ndrg2
2.9 1.3e-03
aUpon exclusion of repeats, unknowns and transcribed sequences, the 245 statistically significant probes at passage 14 (see Fig. 2) were reduced to 101 up-
regulated and 80 down-regulated unique DEGs. These gene sub-sets were subjected to gene ontology (GO) analysis with WebGestalt (http://www.webgestalt.org/) using
the hypergeometric test
bMCM stands for minichromosome maintenance
cFunction taken from WikiPathways analysis done with WebGestalt
dFunction derived from the TSGene database (https://bioinfo.uth.edu//TSGene1.0/). A chi-square test with Yates correction was done with
GraphPad online (http://graphpad.com/quickcalcs/contingency2/)
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like protein 1) were the most recurrent. Up-regulation of
genes coding for centrosome components suggest centro-
some amplification in a similar fashion as experimental
PLK4 overexpression it does [35]. A recurrent observation
in many solid tumors is the presence of supernumerary
centrosomes proposed to have a role in aneuploidy induc-
tion and subsequent tumorigenesis [35].
Moreover, the genes Birc5, Cdc20, Cdca8, Cenpa, Itgb1,
Mif, Nusap1 and Tacc3 have been classified under the MGI’s
gene-phenotype term abnormal mitosis (MP:0004046;
p = 9.0e-08). Birc5, a well-known anti-apoptotic gene
that constitutes the chromosomal passenger complex
and also takes part of spindle and cytokinesis terms, is an
OC growth promoting factor up-regulated by the
luteinizing hormone (LH) [36]. Among several hormone
receptors, OSE cells express LH and FSH receptors. Go-
nadotropins LH and FSH increase at menopause and are
considered OC predisposing factors [37]. On the other
hand, the MCM complex consists of helicases needed for
DNA replication that normally are bound in excess to the
chromatin to counteract replicative stress. As MCM genes
over-expressed transiently in MOSE cells at p14, we
hypothesize that MCM depletion in later passages induce
chromosomal aberrations upon overcoming a mitotic
checkpoint as formerly described in HeLa cells [38].
Additional GO terms significantly enriched among up-
regulated genes were steroid metabolic process, nucleotide
metabolic process and extracellular matrix.
Regarding down-regulated genes at p14, the top
enriched function was mRNA processing covering 11
genes (Table 1), 8 of which were correlated to number of
litters and to ovarian tumor frequency in a previous
transcriptomic study of our laboratory aimed to associ-
ate reproductive parameters and spontaneous tumor
rates across 4 mice strains [39]. RNA processing has
been increasingly connected to the DNA damage re-
sponse [40], which in our results links to apoptosis
through Nupr1 and Cdip1 (Table 1), the latter a regula-
tor of TNF-alpha-mediated, p53-dependent apoptosis
[41]. Furthermore, the splicing factor proline/glutamine-
rich (Sfpq) has been involved in DNA double-strands
break repair [42] and, together with Neat1, Malat1, Atrx
and Crebbp, are catalogued under the cellular compo-
nent nuclear body (Table 1). Interestingly, Malat1 and
Neat1 are long non-coding transcripts that localize in a
particular type of nuclear bodies termed paraspeckles,
which consist of inter-chromatin ribonucleoprotein
structures composed of Neat1 as RNA core plus a min-
imal set of RNA-binding proteins including Sfpq [43].
Paraspeckles are emerging as key regulators of gene ex-
pression at the post-transcriptional level by its ability to
sequestrate certain proteins [44] and retain mature
mRNAs in the nucleus [45, 46]. In addition, Malat1 and
Neat1 were negatively correlated to ovarian tumor
frequency, i.e., their levels were minimal in the ovaries of
mouse strains displaying the highest spontaneous tumor
rates [39]. Downregulation of Malat1 in this MOSE
model along with its inverse correlation with spontan-
eous ovarian tumors in mice, is consistent with a recent
report suggesting a tumor-suppressor role of Malat1 in
gliomas [31]. The above evidence combined suggests
that MOSE cells at p14 tend to minimize the DNA
damage response by downregulating RNA processing
and export.
A second functional domain of downregulated genes
at p14 was that comprised by unfolded & misfolded pro-
tein binding which overlapped with response to ER stress.
Common to both terms were the two major ER-stress
chaperones Hspa5 alias GRP78/BiP and Hsp90b1 alias
GRP94, which provide quality control in protein folding
and overall cell homeostasis [47]. Though in many cases
established cancer cells display a constitutive ER-stress
response to cope with proliferative demand, resist chemo-
therapy and evade immunity [48–50], depression of ER-
stress response without evident apoptotic signaling in
normal proliferating, non-malignant MOSE cells may
simply indicate a decreased synthesis of secretory and
membrane protein products. The third relevant down-
regulated function was tumor suppression comprising 9
genes (Table 1), of which the phosphatase and tensin
homolog (Pten) is the best characterized in OC. Pten
has been implicated in papillary serous OC [51] and
endometroid OC [52] whereas OC mouse models have
been developed by deleting Pten [53, 54].
Protein networks of genes dysregulated by passage 14
Under the assumption that transcript levels are directly
proportional to protein levels, we used the STRING v10
database and tool [55] to mine additional gene interrela-
tionships derived from reported and predicted protein-
protein interactions. Further functional and physical
associations among genes dysregulated by p14 are shown
in the networks of Fig. 3. Robust and highly intercon-
nected networks were obtained by applying strict
analysis settings that included only connected nodes
(proteins), 4 of 7 possible prediction methods and high-
est (0.900)/high (0.700) levels of confidence scores for
up-regulated/down regulated transcripts, respectively.
The majority of connections were at least of 3 types,
with a high frequency of experimental evidence (light
purple connecting lines) supporting the network.
Major hubs in the up-regulated network (Fig. 3a)
comprised 25 genes covering most of the GO terms
mentioned above with mitotic nuclear division genes
highlighted in red. Among these, the 4 hubs composing
the centralspindlin and chromosome passenger com-
plexes plus Ccnb1, Knstrn1, Nusap1, Dlgap5 and Prc1,
were catalogued under the term spindle though the
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latter two are not classified as mitotic nuclear division
genes. Similarly, genes classified under centrosome in-
cluding Dlgap5, Ckap2, Mcm3, Tacc3 plus 6 of the mi-
totic nuclear division genes (see Table 1) were profusely
interconnected. Both the spindle and particularly the
centrosome when amplified have been implicated in
tumorigenesis with aneuploidy and malignant transform-
ation [35]. Centrosome amplification might impair
chromosome segregation in a cell subjected to replica-
tive stress [56]. Consistently, as shown in Table 1, MOSE
cells display upregulation of 6 genes involved in sister
chromatid segregation including Nusap1, a protein that
links microtubules to mitotic chromosomes and induces
extensive bundling of spindle microtubules when is
present in high levels [57]. Similarly, based on multiple
experimental evidences, the kinetochore-related gene
Cenpa was highly interconnected with several of the
above mentioned genes. Interestingly, despite not for-
mally catalogued as nuclear division related, 3 genes of
the MCM, an hexamer protein complex needed to initi-
ate and regulate DNA replication, showed multiple in-
teractions with G1/S and G2/M transition-controlling
cyclins Ccnb1, Ccnb2 and Ccna2, as well as with cyclin
inactivator Cdc20 and the spindle assembler Cdca8.
Another relevant hub in network of Fig. 3a, was that
of Rrm2, coding for the catalytic subunit of ribonucleo-
tide reductase M2. Rrm2 converts ribonucleotides to de-
oxyribonucleotides which are DNA precursors required
by a cell to proliferate continuously. Coherently, Rrm2
was in turn connected to thymidine kinase 1 (Tk1) and
dihydrofolate reductase (Dhfr). Tk1 is a proliferation-
dependent enzyme involved in pyrimidine salvage path-
way while Dhfr is essential for tetrahydrofolate recycling
needed for dTMP synthesis from dUMP. Tk1 has been
considered an unspecific but useful serum cancer
marker [58] and Dhfr was historically used as chemo-
therapeutic target [59]. Finally, Rrm2 was linked both to
the 3 MCM complex genes and to the cell division genes
Cdca8, Birc5, Cdc20 and Top2a.
On the other hand, the network formed among down-
regulated genes by p14 was much less interconnected
(Fig. 3b). As expected, proteins of response to ER stress
were highly interconnected. Of them, Hspa5 (GRP78/
Bip) connected an additional protein trio comprising the
Fig. 3 Protein-protein interactions network among genes transiently expressed at passage 14. The list of 101up-regulated (a) and 80 downregulated
(b) unique gene identities were analysed with STRINGv10 (http://string-db.org/) by limiting the prediction methods to co-expression, experiments,
databases and textmining. The required confidence score was set to highest (0.900) in (a) and high (0.700) in (b) and the unconnected nodes (proteins)
were hidden. In (a), enrichment was set to the term mitotic nuclear division (GO:0007067; p = 2.7e-04) with proteins colored in red. Asterisks and red
ovals depict centralspindlin (*), chromosome passenger (**) and MCM (***) complexes. Blue ovals enclose indicated additional GO terms; ECM stands for
extracellular matrix. In (b), enrichment was set to response to ER stress (GO:0034976; p = 1.4e-03) and asterisks indicate tumor suppressor genes. The type
of interaction is defined by color lines at bottom right. Detailed GO terms are described in Table 1. In (A), the protein D2Ertd750e corresponds to the
updated Knstrn gene
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amyloid beta precursor protein (App), cathepsin B (Ctsb)
and chemokine receptor 4 (Cxcr4). An additional hub was
that of 3 ribosomal proteins plus 2 translational factors.
Of interest was the presence in this network of 5 from 9
putative tumor suppressor genes (see also Table 1).
Earliest DNA copy number changes and its cognate gene
expression profile
Figure 4a shows the DNA copy number profile of MOSE
cells at p18 in an ideogram format illustrating physical
chromosome positions. According to Fig. 2a, p18 is the
stage when the number of DNA aberrations arises
dramatically. By applying moving averages and z-score
filters, discrete segmental gains were detected in chro-
mosomes 7, 10, 11, 15 and 17 while losses were found in
chromosomes 10, 13 and 19. Interestingly, in a previous
genomic study we identified gains of important seg-
ments of chromosomes 10, 11 and 15 in established, late
passage malignant, clonal MOSE cell lines [22]. Since
the microarray-CGH approach is unable to determine
complete polyploidy, we suggest that such segmental
chromosome DNA aberrations detected at p18 might
well correspond to the near-tetraploid genome observed
by Lv et al. in this MOSE model [21]. Therefore, it is
certainly possible that the apparent absence of DNA
copy changes in passages earlier than p18 could corres-
pond to a complete tetraploid genome generated by cyto-
kinesis failure as suggested by these authors [21]. Note
that 7 genes catalogued under cytokinesis and two of the 4
genes composing the chromosome passenger complex, a
key structure engaged in the orderly exit from mitosis
[60], are overexpressed by passage 14 (Table 1). As men-
tioned above, Birc5 (Survivin) expression promotes OC
growth via LH stimulation [36] and has been found over-
expressed in many cancers [61]. Besides its anti-apoptotic
role, overexpression of survivin decreases nucleation of
centrosomal microtubules affecting mitotic spindle dy-
namics and cytokinesis [62].
As shown in Fig. 4b, transcriptional data was superim-
posed over array-CGH data. A large 41 Mbp segment of
chromosome 17 was gained and, upon data smoothing,
showed a concomitant trend of increased expression in
two adjacent segments. This chromosomal segment con-
tained nearly 200 genes for which proteolysis, cell-cycle,
ribosome and RNA processing were the predominant
functional terms (data not shown). In contrast, an
8.2 Mb segment of chromosome 9 showed no copy
number alteration but apparent downregulation of 15
neighbor genes. Later by passage 23, DNA copy number
changes persisted with those of chromosomes 11 and 17
Fig. 4 Segmental aneuploidies profile of MOSE cells prior to the malignant phenotype. Microarray-CGH data (DNA) of culture passage 18
was analyzed and visualized with the Web-aCGH tool [67]. Panel a shows the whole genome CGH profile. Panel b shows overlapped
DNA copy number (purple line) and RNA transcription (blue line) for the indicated chromosomes. Smoothing window was set at 5 Mbp
and z-score at 0.8
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enlarged in size while transcriptional changes dramatic-
ally increased (data not shown). Over 500 genes were
differentially expressed and enriched in focal adhesion (19
genes, R = 10.8, adjP = 6e-13), TNF-alpha NF-kB signaling
pathway (15 genes, R = 8.7, adjP = 2.8e-9), TGF-beta re-
ceptor signaling pathway (8 genes, R = 5.7, adjP = 1e-4),
ECM-receptor interaction (8 genes, R = 11.2, adjP = 6.9e-
6), cell cycle (9 genes, R = 7.6, adjP = 2.4e-5) and riboso-
mal proteins (33 genes, R = 31, adjP = 1e-15). The onco-
genes and oncogene-related transcripts Myc, Mycbp,
Ndrg1, Akt1, Fgfr1op2, Hras1, Rap1b, Rhoa, Rsu, Lyn, Rala
and Tet3 were also within this 500-subset. Overall, the
functional profile of cells at p23 is consistent with a malig-
nant phenotype, in which a few gene expression modules
were identifiable in the chromosomal context although
not physically related to DNA dosage variation in a large
extent. These results suggest that aneuploidy in this
MOSE model emerges with genomic aberrations at p18 in
which chromosomal-driven transcription is not dominant
but apparently follows a more complex pattern that drives
to tumorigenesis.
Mining passage-14 dysregulated genes in clinical
phenotypes of human tumors
The Cancer Genome Atlas (TCGA) is an open reposi-
tory of molecular and clinical information on various tu-
mors including OC. The TCGA ovarian expression
dataset contains log2 data on 11,864 coding genes for
489 cases of high-grade ovarian serous adenocarcinomas
[63]. Available clinical data includes tumor stage, grade
and residual disease, primary therapy outcome, progres-
sion, and platinum response among others. To gain
insight into the possible relevance of premalignant gene
dysregulation in the MOSE model related to human
ovarian tumors, the expression levels the 181 DEG by
p14 were mined in the ovarian TCGA dataset. Limma
ANOVA and t-tests were performed among ovarian
tumor profiles according to platinum status (PS) pro-
gression-free status (PFS) and tumor stage (TS). For the
last case, sub-stages A, B and C were collapsed into sin-
gle II, III and IV stage categories. Statistical results were
ranked and genes with an adjusted p-value < 0.05 and
raw p-value <0,005 were selected. On these lists, the 181
DEG list in p14 MOSE cells was filtered out. PS resulted
in 8 genes, PFS in 3 genes and TS in 6 genes present in
the mouse 181 DEG at p14. SHMT2 and ARHGEF12
were the top significant genes. All genes except SHMT2
and ETNK1, corresponded to down-regulated genes in
MOSE cells at p14. Figure 5 shows these two plus other
5 significant genes. Despite HSP90B1 (GRP94) expres-
sion has been linked to cancer growth and metastasis
[64], decreased HSP90B1 expression as tumor progresses
is consistent with its proposed role as tumor suppressor
in the TSGene database [65]. The ARHGEF12 pattern
was paradoxically opposite in view of its proposed role
as tumor suppressor in breast and colorectal cancer [66].
On the other hand, the platinum status pattern of all
genes in Fig. 5b, including HSP90B1, suggest that their
downregulation would indicate a poor chemotherapeutic
response to cisplatin, the first line agent to treat OC.
Conclusion
The OSE has been regarded as a possible origin of ovar-
ian cancer caused by a chronic damage-repair cycling
upon repetitive ovulatory events. Such damage can be
experimentally replicated in vitro leading to spontaneous
cell transformation. The present study was an attempt to
decode the early, pre-malignant genomic and transcrip-
tomic changes occurring prior to the development of
malignant capacity. Initial segmental aneuploidies were
detected at passage 18 in discrete segments of chromo-
somes 7, 10, 11 and 17. These early DNA aberrations
were preceded by transient differential expression of 181
genes at p14. Based on previous cytogenetic analysis of
this model by Lv et al [21], the functional profile of the
101 up-regulated genes at p14 enabled us to suggest that
an abnormal mitotic process is taking place at p14 and
might include centrosome amplification, cytokinesis
failure and replicative stress. On the contrary, down-
regulated genes indicate impaired RNA processing, re-
sponse to ER stress and tumor suppression. The time
course of transcriptional and genomic alterations of
MOSE cells identified in the present study, particularly
those between p14 and p18, further agree with findings
of Lv et al [21]. Specifically, we propose that profile of
MOSE cells at p14 would correspond to tetraploid cells
leading to a near-tetraploid stage at p18, in which some
of the segmental chromosome aberrations could initiate
and perpetuate the tumorigenic drive. The gene expres-
sion profile of later passages indicates the rise of a
frankly malignant phenotype. Among the limitations of
this study is the difficulty to extrapolate in vitro genomic
and transcriptional changes to a pre-neoplasia arising in
situ at the OSE. It has been described that inclusion cysts
present in aged ovaries may experience a particular
epithelial-mesenchymal transition harboring pre-metaplasic
characteristics. The interaction of OSE with diverse cell
types including interstitial and stromal ovarian cells as well
as the immune cells infiltrating the senescent ovary, will
certainly modulate the fate of a pre-neoplastic tetraploid
cell formed as a consequence of repeated ovulation.
Methods
Cell cultures and nucleic acids extraction
Mouse ovarian surface epithelial (MOSE) cells from 8-
weeks old female C57BL6 mice were isolated and cul-
tured as described [15]. Total RNA and genomic DNA
from culture passages 2, 5, 7, 10, 14, 18, 23, 25 and 28
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were obtained with TRizol reagent following the stand-
ard protocol. The in vitro transformation experiment of
MOSE cells has been described by Roby et al [15].
DNA microarray experiments
Conditions of RNA and DNA labeling, hybridization,
washes and scanning were performed as previously de-
scribed [22, 23]. Microarrays were used in test versus
reference (2-channel) format. The overall experimental
scheme is shown in Fig. 1, top section. Gene transcrip-
tion (RNA) and genome (DNA) microarray hybridiza-
tions were performed using repeated dye-swap with
common reference for both the RNA and the DNA
series. RNA from a C57BL6 newborn male mouse
(Wnbm) and DNA from C57BL6 male peripheral blood
were the reference samples for the two series of experi-
ments, respectively.
Microarray data analysis
Slide images were extracted with the GenePix Pro 5.0
software. GPR files were deposited at the NCI’s micro-
array database, mAdb (https://madb.nci.nih.gov/), and
normalized with loess, background “half” correction
and multi-slide scale adjustment using the DNMAD
tool. Of the total 15,260 cDNA clones in this platform,
11,218 were annotated as known transcripts including
1,025 transcribed loci, 200 of which are moderately or
strongly similar to known genes. For the array-CGH
experiments shown here, 12,275 probes were physic-
ally mapped to the current build of the M musculus
genome resulting in a mean coverage of 221 Kbp/
probe.
Statistical and bioinformatic analysis
Normalized log2 ratio RNA and DNA data consisted of 4
replicates per sample passage with a total of 71 microarray
Fig. 5 Human ovarian tumor analysis of MOSE genes dysregulated at passage 14. Gene transcription data for human OC tumors as well clinical
data was freely available from the TCGA project website. Mouse gene symbols were converted to their corresponding human orthologs. For the
tumor stage data mining (a), data for 473 patients was used. For the platinum status (b), data for 289 patients was available. Limma tests were
applied as described in Methods. Selected genes shown were adj p < 0.05 for tumor stage (a) and raw p < 0.005 for platinum status (b)
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experiments. Limma t-tests with FDR control were done
at Pomelo II (http://pomelo2.iib.uam.es/). For RNA data,
each of all passages from p4 to p28 was compared against
p2 data, regarded as baseline. DEG were cut-off with adj
p < 0.01 and subjected to GO, KEGG and WikiPathway
analysis at WebGestalt (http://www.webgestalt.org/) and
VLAD http://proto.informatics.jax.org/prototypes/vlad/.
Network analysis was done with STRING v10 (http://
string-db.org/). Normalized DNA results were compared
against a reference-to-reference experiment. Data was dis-
played in chromosomal context and smoothed with
WebaCGH [67]. TCGA data was at https://tcga-data.nci.-
nih.gov/docs/publications/ov_2011/ and analyzed with
Pomelo II.
Additional file
Additional file 1: Urzua_RNA_dataset. Contains the complete, loess
normalized dataset of log2 ratio data values for 15,023 cDNA probes in
35 microarrays. Column A contains clone (gene) identity and gene
description. (XLS 10723 kb)
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